pTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancer

Clinical trial NCT04090528 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04090528
Sponsor: University of Wisconsin, Madison
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Castration-resistant Prostate Cancer Metastatic Cancer Prostate Cancer

Start date: 2019-10-21
Primary completion: 2024-11-24
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.